- Home
- NXRT vs STAA Comparison
NXRT vs STAA Comparison
Compare NXRT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXRT
- STAA
- Stock Information
- Founded
- NXRT 2014
- STAA 1982
- Country
- NXRT United States
- STAA United States
- Employees
- NXRT N/A
- STAA N/A
- Industry
- NXRT Real Estate Investment Trusts
- STAA Ophthalmic Goods
- Sector
- NXRT Real Estate
- STAA Health Care
- Exchange
- NXRT Nasdaq
- STAA Nasdaq
- Market Cap
- NXRT 849.7M
- STAA 1.4B
- IPO Year
- NXRT N/A
- STAA N/A
- Fundamental
- Price
- NXRT $33.85
- STAA $27.70
- Analyst Decision
- NXRT Hold
- STAA Hold
- Analyst Count
- NXRT 5
- STAA 8
- Target Price
- NXRT $39.83
- STAA $22.50
- AVG Volume (30 Days)
- NXRT 186.4K
- STAA 714.6K
- Earning Date
- NXRT 10-28-2025
- STAA 10-29-2025
- Dividend Yield
- NXRT 6.03%
- STAA N/A
- EPS Growth
- NXRT N/A
- STAA N/A
- EPS
- NXRT N/A
- STAA N/A
- Revenue
- NXRT $254,446,000.00
- STAA $224,449,000.00
- Revenue This Year
- NXRT N/A
- STAA N/A
- Revenue Next Year
- NXRT $4.22
- STAA $27.59
- P/E Ratio
- NXRT N/A
- STAA N/A
- Revenue Growth
- NXRT N/A
- STAA N/A
- 52 Week Low
- NXRT $29.98
- STAA $13.50
- 52 Week High
- NXRT $48.31
- STAA $38.60
- Technical
- Relative Strength Index (RSI)
- NXRT 53.88
- STAA 64.54
- Support Level
- NXRT $33.20
- STAA $27.52
- Resistance Level
- NXRT $34.87
- STAA $28.38
- Average True Range (ATR)
- NXRT 0.65
- STAA 0.46
- MACD
- NXRT 0.07
- STAA -0.32
- Stochastic Oscillator
- NXRT 47.17
- STAA 42.37
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.